SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001086364-14-001998
Filing Date
2014-02-04
Accepted
2014-02-04 11:37:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 valeant.pharmaceuticals.intl.txt SC 13G/A 11722
  Complete submission text file 0001086364-14-001998.txt   13684
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45947 | Film No.: 14570801
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 EAST 52ND STREET NEW YORK NY 10022
Business Address 40 EAST 52ND STREET NEW YORK NY 10022 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies